↓ Skip to main content

From hormone replacement therapy to regenerative scaffolds: A review of current and novel primary hypothyroidism therapeutics

Overview of attention for article published in Frontiers in endocrinology, October 2022
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (66th percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter
5 X users

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
26 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
From hormone replacement therapy to regenerative scaffolds: A review of current and novel primary hypothyroidism therapeutics
Published in
Frontiers in endocrinology, October 2022
DOI 10.3389/fendo.2022.997288
Pubmed ID
Authors

Maria Heim, Ian J. Nixon, Elaine Emmerson, Anthony Callanan

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 26 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 26 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 5 19%
Lecturer 2 8%
Researcher 2 8%
Lecturer > Senior Lecturer 1 4%
Student > Bachelor 1 4%
Other 3 12%
Unknown 12 46%
Readers by discipline Count As %
Unspecified 5 19%
Nursing and Health Professions 2 8%
Pharmacology, Toxicology and Pharmaceutical Science 1 4%
Biochemistry, Genetics and Molecular Biology 1 4%
Computer Science 1 4%
Other 2 8%
Unknown 14 54%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 October 2022.
All research outputs
#8,480,437
of 26,179,695 outputs
Outputs from Frontiers in endocrinology
#2,537
of 13,372 outputs
Outputs of similar age
#150,127
of 445,310 outputs
Outputs of similar age from Frontiers in endocrinology
#143
of 964 outputs
Altmetric has tracked 26,179,695 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 13,372 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 445,310 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 964 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.